IPO - FIRST TRUST EXCHANGE-TRADED FUND VIII
Form Type: 8-A12B
Filing Date: 2025-04-15
Corporate Action: Ipo
Type: New
Accession Number: 000144554625002701
Filing Summary: First Trust Exchange-Traded Fund VIII is registering a class of securities under the Securities Exchange Act of 1934. The securities being registered are common shares of beneficial interest, with a par value of $0.01 per share, specifically for the FT Vest U.S. Equity Max Buffer ETF – April. The shares have been approved for listing on Cboe BZX Exchange, Inc. A detailed description of these shares is included in the Fund's Prospectus, filed under Registration Numbers 333-210186 and 811-23147 with the SEC on October 7, 2024. This registration enables the shares to be publicly traded, marking an important step in the Fund's establishment.
Additional details:
Title Of Class: Common Shares of Beneficial Interest
Par Value: $0.01
Exchange Name: Cboe BZX
Registration Statement File Number: 333-210186
Irs Number: 33-1903790
Form Type: 485BPOS
Filing Date: 2025-01-10
Corporate Action: Ipo
Type: New
Accession Number: 000144554625000335
Filing Summary: The document filed by First Trust Exchange-Traded Fund VIII on January 10, 2025, pertains to the launch of the FT Vest Nasdaq-100® Conservative Buffer ETF – January. This ETF aims to provide investors with returns that match the price return of the Invesco QQQ TrustSM, Series 1, up to a capped upside while offering protection against the first 20% of losses over a specified one-year target outcome period. The filing includes registration details under the Securities Act of 1933 and the Investment Company Act of 1940, and seeks immediate effectiveness upon filing. The ETF will be available on the Cboe BZX Exchange and is designed to use FLEX Options to create a unique investment opportunity that provides defined risk and return parameters, making it suitable for investors looking for specific investment outcomes.
Additional details:
Registration Statement Number: 333-210186
Management Fees: 0.90%
Annual Fund Operating Expenses: 0.90%
Target Outcome Period: January 21, 2025 - January 16, 2026
Total Annual Fund Operating Expenses: 0.90%
Comments
No comments yet. Be the first to comment!